Advertisement CliniComp Names Chief Financial Officer, Chief Operating Officer - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CliniComp Names Chief Financial Officer, Chief Operating Officer

CliniComp, a global provider of mission critical clinical documentation systems, has appointed James Kesaris as a new chief financial officer and chief operating officer of the company.

Mr Kesaris is expected to report Chris Haudenschild, chairman and CEO of CliniComp and will oversee CliniComp’s financial, operating, marketing and sales functions.

Most recently, Kesaris has worked with SCMS Capital as a business development and investor relations associate.

Prior to that he held the positions of senior vice president and CFO at USE Credit Union, executive vice president of operations at Peninsula Holdings, and CFO at Tatum Partners.

Mr Haudenschild said: “We are pleased to welcome Jim to CliniComp. His proven financial skills and leadership will complement our executive team’s outstanding managerial, operational, technical and business skills. Jim’s expertise will help CliniComp execute against its growth plan and continue to maintain financial and fiscal excellence.”

Mr Kesaris, said: “I look forward to working with Chris and my new colleagues to help achieve an even higher level of success.”